M 274 (Tamoxifen Citrate 20 mg)
Pill with imprint M 274 is White, Round and has been identified as Tamoxifen Citrate 20 mg. It is supplied by Mylan Pharmaceuticals Inc..
Tamoxifen is used in the treatment of breast cancer; breast cancer, adjuvant; breast cancer, metastatic; breast cancer, male; breast cancer, palliative and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 274
Tamoxifen Citrate
- Imprint
- M 274
- Strength
- 20 mg
- Color
- White
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Hormones/antineoplastics, Selective estrogen receptor modulators
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-0274 (Discontinued)
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
magnesium stearate,
microcrystalline cellulose,
sodium lauryl sulfate
Note: Inactive ingredients may vary.
Related Images for "M 274"
More about tamoxifen
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 89 Reviews
- Drug class: hormones/antineoplastics
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.